News
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...
The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.
The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...
In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...
The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...
A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address ...
The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...
The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...
Eli Lilly's Phase 3 study highlights the effectiveness of Orforglipron in lowering blood sugar and promoting weight loss, ...
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results